Vivek Tanavde
Vivek Tanavde is an expert in Biochemistry at Ahmedabad University (India). Vivek Tanavde has authored 48 publications, the most recent in 2024. SLR score: 136 (community average: 125). How the SLR is computed.
LeadR Profile
Biochemistry
Subspecialties:
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2006 - 2024Agency for Science, Technology and Research
2012 - 2024
Ahmedabad University - Associate Professor
2016 - 2024
Number : 48
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Combination of paclitaxel with rosiglitazone induces synergistic cytotoxic effects in ovarian cancer cells. PMID 39730440 — cells, paclitaxel, pharmaceutical preparations, ovary, antineoplastic agents, neoplasms, ovarian neoplasms, natural science disciplines, therapeutics, rosiglitazone, apoptosis, cell cycle | Sci Rep | 2024 | 4 |
| Unravelling the role of Silibinin in targeting CD44+ cancer stem cells: Therapeutic implications, effective strategies and approaches. PMID 38353369 — drug resistance, plants, medicinal, pharmaceutical preparations, stem cells, therapeutics, neoplasms, microscopy, electron, scanning transmission, biological availability, silybin | Phytother Res | 2024 | 1 |
| Correction: A novel 3-miRNA network regulates tumour progression in oral squamous cell carcinoma. PMID 38409134 — cells, carcinoma, squamous cell, micrornas | Biomark Res | 2024 | 1 |
| A novel 3-miRNA network regulates tumour progression in oral squamous cell carcinoma. PMID 37316916 — cells, cell proliferation, carcinoma, squamous cell, micrornas, disease progression, biomarkers, exosomes, cell line, diagnosis, apoptosis, cell cycle | Biomark Res | 2023 | 21 |
| Salinomycin mediated therapeutic targeting of circulating stem like cell population in oral cancer. PMID 34308783 — cell cycle, molecular biology, therapeutics, microscopy, electron, scanning transmission, mouth neoplasms, neoplastic cells, circulating, real-time polymerase chain reaction | J Biomol Struct Dyn | 2021 | 1 |
LeadR Networks
Main global connection map